Molecular marker testing and reporting completeness for adult-type diffuse gliomas in the United States.
Sign Up to like & getrecommendations! Published in 2022 at "Neuro-oncology practice"
DOI: 10.1093/nop/npac079
Abstract: Background A newly developed brain molecular marker (BMM) data item was implemented by US cancer registries for individuals diagnosed with brain tumors in 2018-including IDH and 1p/19q-co-deletion statuses for adult-type diffuse gliomas. We thus investigated… read more here.
Keywords: diffuse gliomas; testing reporting; reporting completeness; adult type ... See more keywords
Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report.
Sign Up to like & getrecommendations! Published in 2017 at "Future microbiology"
DOI: 10.2217/fmb-2017-0106
Abstract: Inappropriate use and overuse of antibiotics are among the most important factors in resistance development, and effective antibiotic stewardship measures are needed to optimize outcomes. Selection of appropriate antimicrobials relies on accurate and timely antimicrobial… read more here.
Keywords: working group; susceptibility testing; susceptibility; report ... See more keywords
The Practical Problem With Carbapenem Testing and Reporting Accurate Bacterial Susceptibilities
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.841896
Abstract: Background: Antibiotic resistance is an evolving issue which requires constant review. Susceptibility breakpoints are revised in line with new microbiological and pharmacological data. Susceptibility breakpoints for carbapenems and Enterobacterales were revised in response to the… read more here.
Keywords: testing reporting; problem carbapenem; practical problem; reporting accurate ... See more keywords